XML 43 R33.htm IDEA: XBRL DOCUMENT v3.21.1
Segment Information (Summary Of Revenue By Segment And Reconciling Items) (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Mar. 31, 2021
Mar. 31, 2020
Segment Reporting Information [Line Items]        
Revenue from Contract with Customer, Excluding Assessed Tax $ 768,767 $ 769,455 $ 2,320,722 $ 2,186,669
Depreciation and amortization 39,988 39,264 120,034 116,341
Net operating profit by segment 223,426 217,500 662,040 586,412
Amortization of acquired intangible assets and corporate assets 7,445 8,272 23,377 21,872
Litigation settlement expenses       (600)
Restructuring expenses     8,673  
Interest income (55) (116) (303) (766)
Interest expense (income), net 5,878 9,968 18,644 31,180
Loss attributable to equity method investments (4,969) (5,295) (9,895) (19,082)
Other, net 5,371 (10,698) 10,647 (15,922)
Income before income taxes 218,005 191,655 644,451 520,994
Impairment of operating lease right-of-use asset 0   2,800  
Operating Segments [Member]        
Segment Reporting Information [Line Items]        
Net operating profit by segment [1] 276,745 268,947 834,463 742,342
Corporate Costs [Member]        
Segment Reporting Information [Line Items]        
Amortization of acquired intangible assets and corporate assets 24,908 24,105 76,456 70,485
Segment Reconciling Items [Member]        
Segment Reporting Information [Line Items]        
Deferred revenue fair value adjustment [2]       (2,102)
Corporate costs 34,950 31,039 106,307 94,933
Amortization of acquired intangible assets and corporate assets 18,369 20,408 57,443 59,495
Restructuring expenses     8,673  
Deferred revenue fair value adjustment [2]       2,102
Interest expense (income), net 5,823 9,852 18,341 30,414
Loss attributable to equity method investments 4,969 5,295 9,895 19,082
Other, net (5,371) 10,698 (10,647) 15,922
Income before income taxes 218,005 191,655 644,451 520,994
Sleep And Respiratory Care [Member]        
Segment Reporting Information [Line Items]        
Impairment of operating lease right-of-use asset     1,600  
Sleep And Respiratory Care [Member] | Operating Segments [Member]        
Segment Reporting Information [Line Items]        
Revenue from Contract with Customer, Excluding Assessed Tax 674,931 679,895 2,042,909 1,923,513
Depreciation and amortization 13,589 14,134 39,979 43,012
Net operating profit by segment [1] 253,693 250,209 763,534 678,468
Software As A Service Before Deferred Revenue Adjustment [Member] | Operating Segments [Member]        
Segment Reporting Information [Line Items]        
Revenue from Contract with Customer, Excluding Assessed Tax 93,836 89,560 277,813 265,258
Software As A Service [Member]        
Segment Reporting Information [Line Items]        
Impairment of operating lease right-of-use asset     1,200  
Software As A Service [Member] | Operating Segments [Member]        
Segment Reporting Information [Line Items]        
Deferred revenue fair value adjustment [2]       (2,102)
Revenue from Contract with Customer, Excluding Assessed Tax 93,836 89,560 277,813 263,156
Depreciation and amortization 1,491 1,025 3,599 2,844
Net operating profit by segment [1] $ 23,052 $ 18,738 $ 70,929 63,874
Deferred revenue fair value adjustment [2]       $ 2,102
[1] During the three and nine months ended March 31, 2021, we recorded $0.0 million and $2.8 million of impairment for our operating lease right-of-use asset, respectively. The impairment related to leases for office space and was recorded within net operating profit. The impairment for the nine months ended March 31, 2021 attributable to Sleep and Respiratory Care was $1.6 million and $1.2 million for SaaS.
[2] The deferred revenue fair value adjustment is a purchase price accounting adjustment related to MatrixCare which was acquired on November 13, 2018.